188 related articles for article (PubMed ID: 22285434)
1. Neuroprotective effects of high affinity Σ1 receptor selective compounds.
Luedtke RR; Perez E; Yang SH; Liu R; Vangveravong S; Tu Z; Mach RH; Simpkins JW
Brain Res; 2012 Mar; 1441():17-26. PubMed ID: 22285434
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
3. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
Ucar H; Cacciaguerra S; Spampinato S; Van derpoorten K; Isa M; Kanyonyo M; Poupaert JH
Eur J Pharmacol; 1997 Sep; 335(2-3):267-73. PubMed ID: 9369382
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.
Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH
J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115
[TBL] [Abstract][Full Text] [Related]
5. A prototypical Sigma-1 receptor antagonist protects against brain ischemia.
Schetz JA; Perez E; Liu R; Chen S; Lee I; Simpkins JW
Brain Res; 2007 Nov; 1181():1-9. PubMed ID: 17919467
[TBL] [Abstract][Full Text] [Related]
6. Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats.
Ajmo CT; Vernon DO; Collier L; Pennypacker KR; Cuevas J
Curr Neurovasc Res; 2006 May; 3(2):89-98. PubMed ID: 16719792
[TBL] [Abstract][Full Text] [Related]
7. Signalling via rat dopamine D2-receptors expressed in mouse fibroblasts is not influenced by compounds binding to the sigma sites of these cells.
Sommermeyer H; Dompert WU; Glaser T
Cell Signal; 1993 Nov; 5(6):747-52. PubMed ID: 8130078
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
9. The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice.
Malik M; Rangel-Barajas C; Sumien N; Su C; Singh M; Chen Z; Huang RQ; Meunier J; Maurice T; Mach RH; Luedtke RR
Br J Pharmacol; 2015 May; 172(10):2519-31. PubMed ID: 25573298
[TBL] [Abstract][Full Text] [Related]
10. An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones.
Lee IT; Chen S; Schetz JA
Eur J Pharmacol; 2008 Jan; 578(2-3):123-36. PubMed ID: 17961544
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of selective dopamine D2 receptor antagonists.
Vangveravong S; McElveen E; Taylor M; Xu J; Tu Z; Luedtke RR; Mach RH
Bioorg Med Chem; 2006 Feb; 14(3):815-25. PubMed ID: 16288878
[TBL] [Abstract][Full Text] [Related]
12. N-(1-arylpropionyl)-4-aryltetrahydropyridines, a new class of high-affinity selective sigma receptor ligands.
Schuster DI; Pan YP; Singh G; Stoupakis G; Cai B; Lem G; Ehrlich GK; Frietze W; Murphy RB
J Med Chem; 1993 Nov; 36(24):3923-8. PubMed ID: 7902869
[TBL] [Abstract][Full Text] [Related]
13. Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.
Entrena JM; Cobos EJ; Nieto FR; Cendán CM; Baeyens JM; Del Pozo E
Psychopharmacology (Berl); 2009 Jul; 205(1):21-33. PubMed ID: 19326101
[TBL] [Abstract][Full Text] [Related]
14. Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands.
Mach RH; Huang Y; Freeman RA; Wu L; Vangveravong S; Luedtke RR
Bioorg Med Chem Lett; 2004 Jan; 14(1):195-202. PubMed ID: 14684327
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
Takahashi S; Sonehara K; Takagi K; Miwa T; Horikomi K; Mita N; Nagase H; Iizuka K; Sakai K
Psychopharmacology (Berl); 1999 Aug; 145(3):295-302. PubMed ID: 10494578
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
Jaen JC; Caprathe BW; Pugsley TA; Wise LD; Akunne H
J Med Chem; 1993 Nov; 36(24):3929-36. PubMed ID: 7902870
[TBL] [Abstract][Full Text] [Related]
17. The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors.
Zvejniece L; Vavers E; Svalbe B; Vilskersts R; Domracheva I; Vorona M; Veinberg G; Misane I; Stonans I; Kalvinsh I; Dambrova M
Br J Pharmacol; 2014 Feb; 171(3):761-71. PubMed ID: 24490863
[TBL] [Abstract][Full Text] [Related]
18. Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures.
DeCoster MA; Klette KL; Knight ES; Tortella FC
Brain Res; 1995 Feb; 671(1):45-53. PubMed ID: 7728532
[TBL] [Abstract][Full Text] [Related]
19. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures.
Nakazawa M; Matsuno K; Mita S
Neurochem Int; 1998 Apr; 32(4):337-43. PubMed ID: 9596556
[TBL] [Abstract][Full Text] [Related]
20. The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice.
Malik M; Rangel-Barajas C; Mach RH; Luedtke RR
Pharmacol Biochem Behav; 2016 Sep; 148():136-44. PubMed ID: 27397487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
